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We are reporting a case of a 29 year-old female with diagnosis of myotonic dystrophy type
1 (Steinert’s disease) with excessive daytime sleepiness, muscle fatigue, snoring, frequent
arousals, non-restorative sleep, and witnessed apneas. Pulmonary function tests revealed
a mild decrease of forced vital capacity. Nocturnal polysomnography showed an increase
of apnea/hypopnea index (85.9 events/h), mainly of central type (236), minimal oxygen
saturation of 72%, and end-tidal carbon dioxide values that varied from 45 to 53 mmHg.
Bi-level positive airway pressure titration was initiated at an inspiratory pressure (IPAP) of 8
and an expiratory pressure (EPAP) of 4 cm H2O. IPAP was then gradually increased to eliminate
respiratory events and improve oxygen saturation. An IPAP of 12cm H20 and an EPAP of 4cm
H2O eliminated all respiratory events, and the oxygen saturation remained above 90%.
Bi-level positive airway pressure treatment at spontaneous/timed mode showed an
improvement in snoring, apneas, and Epworth sleepiness scale decreased from 20 to 10. This
case illustrates the beneﬁcial effects of Bi-level positive airway pressure support in central sleep
apnea syndrome of a patient with myotonic dystrophy type 1.
& 2014 Brazilian Association of Sleep. Production and Hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Type 1 myotonic dystrophy (MD1, known as Steinert's dis-
ease) is a dominant autosomic multisystemic disorder caused
by repeated expansion of trinucleotides (CTG) in the non-
coded region of the gene DMPK, localized in the chromosome 19.
Clinically, MD1 is characterized by the impairment of skeletalep. Production and Hosti
licenses/by-nc-nd/3.0/).
. Akamine).
an Association of Sleepmuscles, eyes, heart, endocrine system, respiratory system and
central nervous system. It is considered the most common
myotonic dystrophy at the beginning of the adult age. The sleep
disorder of the type 1 myotonic dystrophy shows multifactorial
etiology, maybe resulted from the muscle impairment, leading
to alveolar hypoventilation, sleep obstructive respiratory dis-
orders and effects upon the sleep regulatory circuits in theng by Elsevier B.V. This is an open access article under the CC BY-
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initiated during birth until adult age, depending on the quan-
tity of trinucleotides repetitions in that particular individual [1].
Sleep central apnea syndrome is a respiratory disorder char-
acterized by the interruption of the oronasal air ﬂow and the
absence of respiratory effort, of an intermittent or cyclic
character, associated with symptoms (diurnal excessive sleepi-
ness, frequent nocturnal awakenings, fatigue). The diagnosis of
sleep central sleep apnea syndrome requires daytime symp-
toms and index of apnea/hypopnea index higher than 5 events
per hour, being the central events higher than 50% of the
respiratory events [2]. We describe a patient with the diagnosis
of type 1 myotonic dystrophy and sleep central apnea syn-
drome, treated by non-invasive mechanical (NIV) ventilation
with bilevels positive pressure.
2. Case report
A female patient, 29 years of age, with diagnosis of type 1
myotonic dystrophy (Southern-blotting hybridization technique
with PM10MG probe, identifying a 11.0 Kb DNA fragment, which
corresponds to approximately 334 CTG repetitions), being for-
warded for evaluation with complaints of excessive daytime
sleepiness (Epworth Scale¼20), muscle fatigue, fragmented and
non-restorative sleep, snoring and witnessed apneas. At phy-
sical examination, we have observed a body mass of 24.6 kg/m2,
myopathic face, discrete bilateral palpebral ptosis andmyotonic
phenomena in tongue and hands (“hand grip” sign). No signs or
symptoms of cardiomyopathy or cardiac insufﬁciency were
observed. No medication was used. No other associated
comorbities. Pulmonary function tests revealed mild restrictive
ventilatory disorder with forced vital capacity (FVC) of 74% of
the predicted value and the ratio of forced expiratory ﬂow at the
ﬁrst second/FVC of 99%. Diagnostic polysomnography per-
formed at the sleep laboratory, using the American Academy
of Sleep Medicine guidelines[2], demonstrated marked increase
of the apnea/hypopnea index (85.9 events/h). Of the 496
respiratory events, we observed 3 obstructive apneas, 236
central apneas, and 256 hypopneas. Baseline percutaneous
oxygen saturation (SpO2) was of 98%, with mean during sleep
of 91%, and a minimum of 72%. The desaturation index was
95.1 events/hour during REM sleep and of 123.1 events/hour
during non-REM sleep. The patient remained 22.8% of the total
sleep time with SpO2 below 90%. End-tidal carbon dioxide
values varied from 45 to 53mmHg. There were 145 arousals,
the arousal index was 25.1/h. We have not observed Cheyne–
Stokes respiration (Fig. 1). We have opted to treat with non-
invasive mechanical ventilation (NIV) using bilevel positive
pressure. We have also conducted a titration polysomnography
in the laboratory, which normalized the apnea/hypopnea index
(AHI of 3.4 events/h). The total number of respiratory events of
was 16, being just 1 obstructive apnea, 16 hypopneas and none
central/mixed apnea. Arousal index reduced to 15.3/h. Bilevel
titration protocol during polysomnographyconsisted in initiat-
ing the EPAP setting at 4 cm of H2O and IPAP of 8 cm of H2O.
The IPAP was gradually increased to eliminate respiratory
events and oxygen desaturation. As protocol, respiratory rate
was kept at 12 per minute. During the titration procedure, there
was not a single presence of central apneas and the AHI
remained normal. With positive airway inspiratory pressure(IPAP) of 12 cm of water and positive airway expiratory pres-
sure (EPAP) of 4 cm of water, the oxy-hemoglobin saturation
remained above 90% (Fig. 2) troughout the night. There was no
objective improvement of sleep efﬁciency, however, the patient
referred improvement on snoring, apneas and excessive day-
time sleepiness (Epworth¼10).3. Discussion
We reported a case of a patient with diagnosis of MD1 and
sleep central sleep apnea syndrome, treated with Bilevel,
showing improvement of the polysomnography parameters
and some of the sleep-related symptoms. The presence of
central apneas in patients with MD1 has been reported in
patients with MD1 [3]. The etiology might be the result of a
central nervous system impairment, with alterations on the
central ventilatory control and afferent circuits from the
intrapulmonary chemo and mechanoreceptors. The physio-
pathology might also include central apnea derived from an
inadequate response to hypoxia and hypercapnia (loop gain
anomaly) associated with hypercapnic respiratory insufﬁ-
ciency. Patients with periodic respiration and/or central
apnea have ventilatory control instabilities. The loop gain is
a physiologic measurement of this mentioned instability.
There are several components of the “loop gain”: the central
controller (controller gain), the efﬁciency of carbonic gas
excretion (plant gain) and the delays of blood circulation
(mixing gain). As we observed the predominance of central
apneas in this patient, we believe that we were faced with an
anomaly of the central ventilatory command (controller gain).
The treatment of central sleep apnea syndrome might be
obtained with positive airway continuous pressure (CPAP),
nocturnal supplemental oxygen, or servo-adaptive ventilator.
The use of Bilevel was associated, in patients with Cheyne–
Stokes respiration, to a worsening of the central apneas and
the periodic breathing [4]. Bilevel, at spontaneous/timed mode
(S/T), might be considered for the correction of AHI during the
central apnea syndrome associated with congestive heart fail-
ure, only if there was a therapeutic failure with the use of
CPAP, supplemental oxygen and servo-adaptative ventilator [5].
Restrictive ventilatory disorders and alveolar hypoventila-
tion syndromes in neuromuscular diseases are usually treated
with Bilevel, providing support pressure and working volume.
CPAP is not an adequate choice for this situation due to the
continuous positive airway pressure, without generating tidal
volume. The use of supplemental oxygen is not recommended
due to the risk of worsening hypercapnia and gas exchanges.
Considering the clinical picture, the natural history of the
disease with possible evolution to restrictive ventilatory dis-
order and alveolar hypoventilation syndrome and the over-
lapping of the symptoms, we opted by treatment of Bilevel
ventilatory support with spontaneous/timed mode (S/T). Neu-
romuscular diseases may demonstrate progressive muscle
weakness with restrictive ventilatory disorder, alveolar hypo-
ventilation syndrome, sleep obstructive apnea syndrome and
other respiratory disorder related to sleep. The use of NIV with
Bilevel is well established for this situation, with improvement
of the respiratory symptoms, reduction of the respiratory
workload, improvement of gas exchanges, improvement of
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Fig. 1 – Diagnostic polysomnography report, demonstrating numerous respiratory events of central type (AC) and oxygen
desaturation (SpO2%).
S l e e p S c i e n c e 7 ( 2 0 1 4 ) 1 1 7 – 1 2 1 119patient's comfort, decreased risk of intubation, improvement of
the duration and the quality of sleep, improvement of the
functional status, and increased lifespan [6].On the case here described, although the diagnostic poly-
somnography did not demonstrate important hypercapnia,
the positive improvement showed by the patient suggests
Fig. 2 – Bilevel titration polysomnography. Absence of central respiratory events and normalization of apnea/hypopnea and
oxygen saturation indexes.
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nia. A situation where the treatment with Bilevel is beneﬁcial,
in contrast with patients with congestive heart failure and
Cheyne–Stokes respiration. To our knowledge, there is no
speciﬁc information about the management of ventilatory
support in central apnea in patients with MD1.
This case illustrates the beneﬁcial effects of Bilevel for the
correction of respiratory events of central origin, oxygen
desaturation, and the sleep-related symptoms in a patient
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